{
  "docId": "019de517-367d-70bd-91a8-e8364be38738",
  "docSlug": "a077d4720a58dc83fc9a6e723d013650",
  "documentTitle": "Enfusion | Investor Presentation Deck | 20 slides",
  "authorId": "enfusion",
  "authorName": "Enfusion",
  "documentKindSlug": "shareholder-letter",
  "documentKindLabel": "Shareholder letter",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 14,
  "pageCount": 20,
  "prevPage": 13,
  "nextPage": 15,
  "slideType": "other",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 30,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de517-367d-70bd-91a8-e8364be38738/14",
  "deckHref": "/decks/019de517-367d-70bd-91a8-e8364be38738",
  "deckJsonHref": "/decks/019de517-367d-70bd-91a8-e8364be38738.json",
  "deckAnchorHref": "/decks/019de517-367d-70bd-91a8-e8364be38738#slide-14",
  "components": [
    {
      "bbox": {
        "h": 0.02,
        "w": 0.068,
        "x": 0.037,
        "y": 0.934
      },
      "kind": "image",
      "text": null,
      "attrs": {},
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ae33f8dd-d06d-464c-9ec2-410dc84528c1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.015,
        "w": 0.46,
        "x": 0.372,
        "y": 0.116
      },
      "kind": "paragraph",
      "text": "(dollars and shares in thousands, except par value)",
      "attrs": {},
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2892cda3-e9fd-4869-b251-8efa8edd1308",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.01,
        "w": 0.015,
        "x": 0.958,
        "y": 0.945
      },
      "kind": "paragraph",
      "text": "14",
      "attrs": {},
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "92877535-ab58-4356-ae01-4879de781ca6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.01,
        "w": 0.176,
        "x": 0.77,
        "y": 0.945
      },
      "kind": "source-note",
      "text": "©2023 ENFUSION, ALL RIGHTS RESERVED.",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "55a5fd2b-959f-4bc4-acff-27dcba4eda7d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.767,
        "w": 0.587,
        "x": 0.208,
        "y": 0.15
      },
      "kind": "table",
      "text": "ASSETS Current assets: Cash and cash equivalents $ 31,652 $ 62,545 Accounts receivable, net 24,855 25,855 Prepaid expenses 4,079 6,105 Other current assets 1,459 2,303 Total current assets 62,045 96,808 Property and equipment, net 18,136 15,759 Right-of-use-assets, net 15,734 6,732 Other assets 5,825 4,484 Total assets $ 101,740 $ 123,783 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $ 1,341 $ 1,685 Accrued expenses and other current liabilities 10,629 11,665 Current portion of lease liabilities 4,403 4,030 Total current liabilities 16,373 17,380 Lease liabilities, net of current portion 12,090 2,959 Total liabilities 28,463 20,339 Stockholders' Equity: Preferred stock, $0.001 par value; 100,000 shares authorized, no shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively Class A common stock, $0.001 par value; 1,000,000 shares authorized, 88,217 and 70,860 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively 88 71 Class B common stock, $0.001 par value; 150,000 shares authorized, 39,199 and 43,199 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively 39 43 Additional paid-in capital 224,710 244,260 Accumulated deficit (173,555) (178,863) Accumulated other comprehensive loss (548) (504) Total stockholders' equity attributable to Enfusion, Inc. 50,734 65,007 Non-controlling interests 22,543 38,437 Total stockholders' equity 73,277 103,444 Total liabilities and stockholders' equity $ 101,740 $ 123,783",
      "attrs": {},
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "74290cbf-b0f5-4100-ad64-e9db32190a08",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.026,
        "w": 0.46,
        "x": 0.372,
        "y": 0.09
      },
      "kind": "title",
      "text": "ENFUSION, INC. CONSOLIDATED BALANCE SHEETS",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2a3e71e0-d2a8-439e-bf18-f2b2bc828c30",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "0d5eccbc-b1ea-4ef4-bbde-fdda9a33e89a",
      "evidence": "table/data: ASSETS Current assets: Cash and cash equivalents $ 31,652 $ 62,545 Accounts receivable, net 24,855 25,855...",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}